This text was was first published on www.svds-at-target.eu
In November 2018 the Zoom@SVDs study included the 60th participant, thereby reaching its milestone for midterm recruitment. The Zoom@SVDs study is an observational study that aims to advance our understanding of Small Vessel Disease, a condition in which the small blood vessels in the brain are damaged. We do this by zooming in on the small vessels with one of the strongest MRI scanners currently available for humans, located in the UMC Utrecht.
This study builds on a collaboration between the LMU in Munich (Germany) and the UMC Utrecht (Netherlands). In order to undergo a scan in the strong MRI in Utrecht, the 28 participants that were recruited so far in Munich travelled from all over Germany to Utrecht for an additional visit. Of course, the logistics of this study are very challenging, because flight tickets, train tickets and hotels have to be arranged as well. Also, all study information needed to be officially translated from Dutch to German and the researchers in Utrecht had to refresh their German language skills. However, these joined efforts have resulted in fast recruitment with happy participants and high-quality data.
Analyses of the first patient data have just started, of which we aim to publish the first results in the coming year. Of course, we will continue our recruitment and will continue to work in close collaboration. This study builds on our dedicated participants and good teamwork; thanks to all involved!
